14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy

Clinical trial NCT05191888 · UNKNOWN

Trial details

NCT number: NCT05191888
Sponsor: Kaohsiung Medical University
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Helicobacter Pylori Eradication

Start date: 2021-08-06
Primary completion: 2024-12-31
Enrollment: 906

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.